Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
PwC
Biotech
Biopharma dealmaking still rising, but M&A value steady: PwC
As of May 15, deal volume across the pharma and life sciences sector was up 20% over the previous-year period.
James Waldron
Jun 20, 2024 8:27am
Biotech IPO window will ‘gradually reopen’ in 2024: PwC
Dec 14, 2023 9:39am
M&A values halve, volumes plunge. Will we ever see deals again?
Dec 8, 2022 8:25am
Expect a 'buoyant year' in biopharma M&A with $1.7T to deploy
Feb 15, 2022 8:00am
